🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary objective of this study is to assess the pharmacokinetics (PK) ...
Status
Completed
Location
Xuhui Central Hospital
Start Date
2020-10-26
Trial ID
NCT04555733
Treatments Being Tested
E2006-A001-108 is a 4-period crossover study designed to demonstrate that t...
Status
Completed
Location
NeuroTrials Research, Inc
Start Date
2016-11-21
Trial ID
NCT03008447
The goal of this clinical trial is to learn about how certain medications u...
Status
Recruiting
Location
VCU Institute for Drug and Alcohol Studies
Start Date
2025-05-27
Trial ID
NCT06981195
Treatments Being Tested
The goal of this clinical trial is to learn if Lemborexant works to treat r...
Status
Terminated
Location
St. Michael's Hospital, Unity Health Toronto
Start Date
2024-09-25
Trial ID
NCT06843187
Treatments Being Tested
The goal of this clinical trial is to investigate the 1-month treatment eff...
Status
Not Yet Recruiting
Location
Chulalongkorn University
Start Date
2026-09-01
Trial ID
NCT07683442
This study will be conducted to determine the dose response of lemborexant ...
Status
Completed
Location
Facility #1
Start Date
2016-12-20
Trial ID
NCT03001557
The goal of this randomized, placebo-controlled, double-blind, crossover tr...
Status
Completed
Location
Chulalongkorn University
Start Date
2023-02-01
Trial ID
NCT05763329
Shift Work Sleep Disorder (SWSD) are caused by working shifts with a wake-u...
Status
Unknown
Location
Phramongkutklao Hospital
Start Date
2024-08
Trial ID
NCT06496282
Treatments Being Tested
Insomnia is a highly common, chronic disorder that is distressful for the p...
Status
Recruiting
Location
Nova Scotia Health
Start Date
2023-12-11
Trial ID
NCT06093126
Treatments Being Tested
This is a randomized, double-blind, placebo- and active-controlled, 4-perio...
Status
Completed
Location
Maastricht University
Start Date
2015-11
Trial ID
NCT02583451